An in-depth analysis based on the disease courses, and especially relapsing-remitting (RRMS) and secondary progressive types of MS (SPMS), revealed that RRMS patients instead of SPMS showed significantly lower concentration levels of IL-1a, IL-8, and CCL4 compared to HCs (Figure 6). Here, CCL4 is linked to myeloid sarcoma.